Lyster HS - Search Results

1

Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.

Hamour IM, Lyster HS, Burke MM, Rose ML, Banner NR. Hamour IM, et al. Among authors: lyster hs. Transplantation. 2007 Mar 15;83(5):570-6. doi: 10.1097/01.tp.0000253883.52525.7c. Transplantation. 2007. PMID: 17353776

2

Coadministration of itraconazole and tacrolimus after thoracic organ transplantation.

Banerjee R, Leaver N, Lyster H, Banner NR. Banerjee R, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1600-2. doi: 10.1016/s0041-1345(00)02608-7. Transplant Proc. 2001. PMID: 11267435 No abstract available.

3

Management of an ABO-incompatible lung transplant.

Banner NR, Rose ML, Cummins D, de Silva M, Pottle A, Lyster H, Doyle P, Carby M, Khaghani A. Banner NR, et al. Am J Transplant. 2004 Jul;4(7):1192-6. doi: 10.1111/j.1600-6143.2004.00438.x. Am J Transplant. 2004. PMID: 15196081 Free article.

4

Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation.

Lyster H, Panicker G, Leaver N, Banner NR. Lyster H, et al. Transplant Proc. 2004 Dec;36(10):3167-70. doi: 10.1016/j.transproceed.2004.10.062. Transplant Proc. 2004. PMID: 15686720

5

Intravenous inotropic agents in heart failure.

Banner NR, Lyster H, Prabhakar A, Rahman-Haley S. Banner NR, et al. Br J Hosp Med (Lond). 2008 Jan;69(1):24-30. doi: 10.12968/hmed.2008.69.1.28037. Br J Hosp Med (Lond). 2008. PMID: 18293724

6

Chronic kidney disease after heart transplantation.

Hamour IM, Omar F, Lyster HS, Palmer A, Banner NR. Hamour IM, et al. Among authors: lyster hs. Nephrol Dial Transplant. 2009 May;24(5):1655-62. doi: 10.1093/ndt/gfn759. Epub 2009 Jan 23. Nephrol Dial Transplant. 2009. PMID: 19168463

7

Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.

Lyster H, Leaver N, Hamour I, Palmer A, Banner NR. Lyster H, et al. Nephrol Dial Transplant. 2009 Dec;24(12):3872-5. doi: 10.1093/ndt/gfp386. Epub 2009 Aug 7. Nephrol Dial Transplant. 2009. PMID: 19666660

8

De novo HLA sensitization and antibody mediated rejection following pregnancy in a heart transplant recipient.

O'Boyle PJ, Smith JD, Danskine AJ, Lyster HS, Burke MM, Banner NR. O'Boyle PJ, et al. Among authors: lyster hs. Am J Transplant. 2010 Jan;10(1):180-3. doi: 10.1111/j.1600-6143.2009.02875.x. Epub 2009 Nov 24. Am J Transplant. 2010. PMID: 19951281 Free article.

9

ATP-binding cassette subfamily B member 1 polymorphisms do not determine cyclosporin exposure, acute rejection or nephrotoxicity after heart transplantation.

Taegtmeyer AB, Breen JB, Smith J, Burke M, Leaver N, Pantelidis P, Lyster H, Yacoub MH, Barton PJ, Banner NR. Taegtmeyer AB, et al. Transplantation. 2010 Jan 15;89(1):75-82. doi: 10.1097/TP.0b013e3181c342fd. Transplantation. 2010. PMID: 20061922

10

Is monitoring milrinone therapy useful in advanced heart failure?

Vazir A, Leaver N, Lyster H, Alexanian A, Wilton P, Banner NR. Vazir A, et al. Int J Cardiol. 2011 Jun 16;149(3):380-1. doi: 10.1016/j.ijcard.2011.02.068. Epub 2011 Mar 29. Int J Cardiol. 2011. PMID: 21450357 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page